Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | PTGER4 | P35408 | 7/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13671617 | 0.85 | CNR1 (0.50) | CNR1MCL1PTGER4CYP2D6PARP1 | |
| SCHEMBL4253145 | 0.84 | ALDH1A1 (0.42) | CNR1MCL1ALDH1A1LMNAPTGER4 | |
| SCHEMBL4250971 | 0.83 | CNR1 (0.46) | CNR1MCL1ALDH1A1LMNAPTGER4 | |
| SCHEMBL4252020 | 0.82 | CNR1 (0.48) | CNR1MCL1ALDH1A1PTGER4CYP2D6 | |
| SCHEMBL4245639 | 0.81 | CA12 (0.45) | CNR1MCL1PTGER4PARP1HDAC3 | |
| SCHEMBL31647277 | 0.80 | PTGER4 (0.60) | CNR1ALDH1A1LMNAPTGER4CYP2D6 | |
| SCHEMBL3775553 | 0.80 | PTGER4 (0.60) | CNR1ALDH1A1LMNAPTGER4CYP2D6 | |
| SCHEMBL24273625 | 0.79 | PTGER4 (0.62) | CNR1ALDH1A1LMNAPTGER4CYP2D6 | |
| SCHEMBL6114223 | 0.77 | PTGER4 (0.57) | CNR1PTGER4CYP2D6KMT2AHDAC3 | |
| SCHEMBL8591344 | 0.77 | PTGER4 (0.52) | CNR1ALDH1A1LMNAPTGER4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005056532-A1 | INDAZOLE DERIVATIVES WHICH INTERACT WITH THE G-PROTEIN COUPLED RECEPTOR FAMILY | BIOFOCUS DISCOVERY LIMITED (GB) | 2005-06-23 | — | — | WO | claimed |
| EP-2117577-A1 | G PROTEIN-COUPLED RECEPTOR AND MODULATORS THEREOF FOR THE TREATMENT OF GABA-RELATED NEUROLOGICAL DISORDERS INCLUDING SLEEP-RELATED DISORDERS | Arena Pharmaceuticals, Inc. (US) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008085888-A1 | G PROTEIN-COUPLED RECEPTOR AND MODULATORS THEREOF FOR THE TREATMENT OF GABA-RELATED NEUROLOGICAL DISORDERS INCLUDING SLEEP-RELATED DISORDERS | ARENA PHARMACEUTICALS, INC. (US) | 2008-07-17 | — | — | WO | disclosed |
| WO-2005056532-A1 | INDAZOLE DERIVATIVES WHICH INTERACT WITH THE G-PROTEIN COUPLED RECEPTOR FAMILY | BIOFOCUS DISCOVERY LIMITED (GB) | 2005-06-23 | — | — | WO | disclosed |